Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9UHN1
UPID:
DPOG2_HUMAN
Alternative names:
DNA polymerase gamma accessory 55 kDa subunit; Mitochondrial DNA polymerase accessory subunit; MtPolB; PolG-beta
Alternative UPACC:
Q9UHN1; O00419; Q0IJ81; Q96GW2; Q9UK35; Q9UK94
Background:
DNA polymerase subunit gamma-2, mitochondrial, also known as DNA polymerase gamma accessory 55 kDa subunit, plays a crucial role in mitochondrial DNA replication and repair. It enhances the processivity of DNA synthesis by binding to single-stranded DNA. This protein is pivotal for mitochondrial function and cellular energy production.
Therapeutic significance:
Mutations in DNA polymerase subunit gamma-2 are linked to several mitochondrial disorders, including Progressive external ophthalmoplegia and Mitochondrial DNA depletion syndromes. Understanding its function could lead to novel therapeutic strategies for these debilitating conditions.